Comprehensive profiling of DNA methylation in colorectal cancer reveals subgroups with distinct clinicopathological and molecular features

BackgroundMost previous studies of the CpG island methylator phenotype (CIMP) in colorectal cancer (CRC) have been conducted on a relatively small numbers of CpG sites. In the present study we performed comprehensive DNA methylation profiling of CRC with the aim of characterizing CIMP subgroups.MethodsDNA methylation at 1,505 CpG sites in 807 cancer-related genes was evaluated using the Illumina GoldenGate® methylation array in 28 normal colonic mucosa and 91 consecutive CRC samples. Methylation data was analyzed using unsupervised hierarchical clustering. CIMP subgroups were compared for various clinicopathological and molecular features including patient age, tumor site, microsatellite instability (MSI), methylation at a consensus panel of CpG islands and mutations in BRAF and KRAS.ResultsA total of 202 CpG sites were differentially methylated between tumor and normal tissue. Unsupervised hierarchical clustering of methylation data from these sites revealed the existence of three CRC subgroups referred to as CIMP-low (CIMP-L, 21% of cases), CIMP-mid (CIMP-M, 14%) and CIMP-high (CIMP-H, 65%). In comparison to CIMP-L tumors, CIMP-H tumors were more often located in the proximal colon and showed more frequent mutation of KRAS and BRAF (P < 0.001).ConclusionsComprehensive DNA methylation profiling identified three CRC subgroups with distinctive clinicopathological and molecular features. This study suggests that both KRAS and BRAF mutations are involved with the CIMP-H pathway of CRC rather than with distinct CIMP subgroups.

[1]  M. Loda,et al.  CpG island methylator phenotype-low (CIMP-low) in colorectal cancer: possible associations with male sex and KRAS mutations. , 2006, The Journal of molecular diagnostics : JMD.

[2]  Wei Jiang,et al.  High-throughput DNA methylation profiling using universal bead arrays. , 2006, Genome research.

[3]  R. Wolff,et al.  Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. , 2005, Gastroenterology.

[4]  Ru-Fang Yeh,et al.  Epigenetic profiling reveals etiologically distinct patterns of DNA methylation in head and neck squamous cell carcinoma. , 2009, Carcinogenesis.

[5]  M. Loda,et al.  Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample. , 2007, The Journal of molecular diagnostics : JMD.

[6]  R. Ward,et al.  CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability. , 2002, Gastroenterology.

[7]  Marina Bibikova,et al.  A Comprehensive Microarray-Based DNA Methylation Study of 367 Hematological Neoplasms , 2009, PloS one.

[8]  B. Iacopetta,et al.  Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands , 2002, Gut.

[9]  D. Takai,et al.  Silencing of HTR1B and reduced expression of EDN1 in human lung cancers, revealed by methylation-sensitive representational difference analysis , 2001, Oncogene.

[10]  D. Ahlquist,et al.  Aberrant methylation of the eyes absent 4 gene in ulcerative colitis-associated dysplasia. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[11]  N. Perrimon,et al.  Specificities of heparan sulphate proteoglycans in developmental processes , 2000, Nature.

[12]  P. Laird,et al.  Epigenetic stem cell signature in cancer , 2007, Nature Genetics.

[13]  J. Issa.  CpG island methylator phenotype in cancer , 2004, Nature Reviews Cancer.

[14]  Jian-Bing Fan,et al.  GoldenGate assay for DNA methylation profiling. , 2009, Methods in molecular biology.

[15]  B. Iacopetta,et al.  Prognostic Significance of Microsatellite Instability and Ki-ras Mutation Type in Stage II Colorectal Cancer , 2003, Oncology.

[16]  M. Kloor,et al.  Mutations in both KRAS and BRAF may contribute to the methylator phenotype in colon cancer. , 2008, Gastroenterology.

[17]  L. Hubert,et al.  A general statistical framework for assessing categorical clustering in free recall. , 1976 .

[18]  John Quackenbush,et al.  Comprehensive Biostatistical Analysis of CpG Island Methylator Phenotype in Colorectal Cancer Using a Large Population-Based Sample , 2008, PloS one.

[19]  Randy D. Gascoyne,et al.  Array-based DNA methylation profiling in follicular lymphoma , 2009, Leukemia.

[20]  Kurt Berlin,et al.  Novel method for high throughput DNA methylation marker evaluation using PNA-probe library hybridization and MALDI-TOF detection , 2006, Nucleic acids research.

[21]  Peter A. Jones,et al.  Epigenetics in cancer. , 2010, Carcinogenesis.

[22]  P. Laird,et al.  CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer , 2006, Nature Genetics.

[23]  Jonathan Pevsner,et al.  DNA methylation signatures within the human brain. , 2007, American journal of human genetics.

[24]  N. Copeland,et al.  Multiple Isoforms of Heparan Sulfate d-Glucosaminyl 3-O-Sulfotransferase , 1999, The Journal of Biological Chemistry.

[25]  J. Jass.  Classification of colorectal cancer based on correlation of clinical, morphological and molecular features , 2007, Histopathology.

[26]  B. Iacopetta,et al.  An improved quality control for bisulfite-PCR-based DNA methylation analysis: cycle threshold value , 2008, Clinical chemistry and laboratory medicine.

[27]  N. Matsubara,et al.  Colorectal cancer with mutation in BRAF, KRAS, and wild-type with respect to both oncogenes showing different patterns of DNA methylation. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  Megan F. Cole,et al.  Control of Developmental Regulators by Polycomb in Human Embryonic Stem Cells , 2006, Cell.

[29]  Kimberly D Siegmund,et al.  Epigenetic profiling of somatic tissues from human autopsy specimens identifies tissue- and individual-specific DNA methylation patterns. , 2009, Human molecular genetics.

[30]  N. Ahuja,et al.  Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Miguel Alaminos,et al.  A microarray-based DNA methylation study of glioblastoma multiforme , 2009, Epigenetics.

[32]  B. Iacopetta,et al.  Routine detection of the replication error phenotype in clinical tumor specimens using fluorescence-SSCP. , 2000, BioTechniques.

[33]  B. Christensen,et al.  Aging and Environmental Exposures Alter Tissue-Specific DNA Methylation Dependent upon CpG Island Context , 2009, PLoS genetics.

[34]  M. Ferracin,et al.  The methylator phenotype in microsatellite stable colorectal cancers is characterized by a distinct gene expression profile , 2008, The Journal of pathology.

[35]  P. Laurent-Puig,et al.  Hypermethylator phenotype in sporadic colon cancer: study on a population-based series of 582 cases. , 2008, Cancer research.

[36]  A. Serretti,et al.  HTR1B as a risk profile maker in psychiatric disorders: a review through motivation and memory , 2009, European Journal of Clinical Pharmacology.

[37]  J. Ptak,et al.  Somatic mutations of GUCY2F, EPHA3, and NTRK3 in human cancers , 2006, Human mutation.

[38]  R. Wolff,et al.  A Comparison of Colon and Rectal Somatic DNA Alterations , 2009, Diseases of the colon and rectum.

[39]  J. Herman,et al.  CpG island methylator phenotype in colorectal cancer. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[40]  J. Ragoussis,et al.  CpG methylation profiling in VHL related and VHL unrelated renal cell carcinoma , 2009, Molecular Cancer.

[41]  Minoru Toyota,et al.  Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer , 2007, Proceedings of the National Academy of Sciences.

[42]  K. Kawakami,et al.  BRAF mutations are associated with distinctive clinical, pathological and molecular features of colorectal cancer independently of microsatellite instability status , 2006, Molecular Cancer.

[43]  J. Meyerhardt,et al.  CpG island methylator phenotype-low (CIMP-low) colorectal cancer shows not only few methylated CIMP-high-specific CpG islands, but also low-level methylation at individual loci , 2008, Modern Pathology.

[44]  Y. Yagi,et al.  Methylation-associated silencing of heparan sulfate D-glucosaminyl 3-O-sulfotransferase-2 (3-OST-2) in human breast, colon, lung and pancreatic cancers , 2003, Oncogene.

[45]  M. Loda,et al.  CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies , 2006, Gut.